A citation-based method for searching scientific literature

HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.
An-Hsun Chou, Si-Ying Chen, Tu-Hsueh Yeh, Yi-Hsin Weng, Hung-Li Wang. Neurobiol Dis 2011
Times Cited: 70



H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
Hung-Li Wang, Su-Huei Hu, An-Hsun Chou, Shang-Seng Wang, Yi-Hsin Weng, Tu-Hsueh Yeh. Neuropharmacology 2013
Times Cited: 25




List of shared articles



Times cited

Experimental and Clinical Strategies for Treating Spinocerebellar Ataxia Type 3.
Zijian Wang. Neuroscience 2018
7

Pharmacological Therapies for Machado-Joseph Disease.
Sara Duarte-Silva, Patrícia Maciel. Adv Exp Med Biol 2018
10

Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Xiaoling Li, Hongmei Liu, Paula L Fischhaber, Tie-Shan Tang. Prog Neurobiol 2015
46

T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
An-Hsun Chou, Ying-Ling Chen, Ching-Chi Chiu, Shin-Je Yuan, Yi-Hsin Weng, Tu-Hsueh Yeh, Yun-Lian Lin, Jim-Min Fang, Hung-Li Wang. Neuropharmacology 2015
18

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
50

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Jorge Diogo Da Silva, Andreia Teixeira-Castro, Patrícia Maciel. Neurotherapeutics 2019
21

Motor Performances of Spontaneous and Genetically Modified Mutants with Cerebellar Atrophy.
Robert Lalonde, Catherine Strazielle. Cerebellum 2019
8

Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Maria do Carmo Costa, Naila S Ashraf, Svetlana Fischer, Yemen Yang, Emily Schapka, Gnanada Joshi, Thomas J McQuade, Rahil M Dharia, Mark Dulchavsky, Michelle Ouyang,[...]. Brain 2016
28

Animal Models of Machado-Joseph Disease.
Jana Schmidt, Thorsten Schmidt. Adv Exp Med Biol 2018
0

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
13

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
54

From mice to men: lessons from mutant ataxic mice.
Jan Cendelin. Cerebellum Ataxias 2014
46


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy